C

Carolina Blood and Cancer Care Associates | Rock Hill, SC

Research site

(Unclaimed)

Location

1583 Health Care Drive, Rock Hill, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Cyclophosphamide

Bendamustine

Azacitidine

Farydak

Docetaxel

CG-806

AZD7442

Paclitaxel

Eftilagimod Alpha

Idelalisib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

This study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic lymphocytic...

Active, not recruiting

Non-Hodgkin's Lymphoma

Small Lymphocytic Lymphoma

Drug: CG-806

Status recently updated

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy (AIPAC-003)

The goal of this clinical trial is to compare the safety and efficacy of eftilagimod alpha (efti) in combination with paclitaxel standard of care che...

Enrolling

Active, not recruiting

Breast Carcinoma

Biological: eftilagimod alpha

Drug: Paclitaxel

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have previously received treatment with...

Active, not recruiting

Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia

Drug: Idelalisib

Drug: Bendamustine